Twist Bioscience Corporation has announced the appointment of Trynka Shineman Blake to its board of directors. She will also serve on the audit committee. Ms. Shineman Blake, who previously served as CEO of Vistaprint, brings extensive experience in corporate governance, customer experience, and digital transformation. Her appointment is expected to contribute to Twist Bioscience's strategic direction and growth as the company works towards achieving adjusted EBITDA breakeven and delivering innovative solutions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.